✦ LIBER ✦

Leptin therapy for partial lipodystrophy linked to a PPAR-γ mutation

✍ Scribed by Jean-Marc Guettier; Jean Y. Park; Elaine K. Cochran; Christine Poitou; Arnaud Basdevant; Muriel Meier; Karine Clément; Jocelyne Magré; Phillip Gorden

Book ID: 108703977
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 224 KB
Volume: 68
Category: Article
ISSN: 0300-0664
DOI: 10.1111/j.1365-2265.2007.03095.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction of neutral gene flow due to th

Reduction of neutral gene flow due to the partial sterility of heterozygotes for a linked chromosome mutation

✍ Franco Spirito; Marco Rizzoni; Elena Lolli; Carla Rossi 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 687 KB

Human lipodystrophies linked to mutation

Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence

✍ Caron, M; Auclair, M; Donadille, B; Béréziat, V; Guerci, B; Laville, M; Narbonne 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 444 KB

Electrophilic PPARγ ligands inhibit corn

Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: A potentially novel therapy for corneal scarring

✍ A.E. Kuriyan; G.M. Lehmann; A.A. Kulkarni; C.F. Woeller; S.E. Feldon; H.B. Hindm 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 979 KB

Failure of lamin A/C to functionally ass

Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription

✍ Cristina Capanni; Vittoria Cenni; Elisabetta Mattioli; Patrizia Sabatelli; Andre 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 700 KB

Efficacy and safety of the PPARγ partial

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

✍ Kim Henriksen; Inger Byrjalsen; Per Qvist; Henning Beck-Nielsen; Gitte Hansen; B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 1 views

## Abstract ## Background Treatment of patients with perioxisome proliferator‐activated receptor‐γ full agonists are associated with weight gain, heart failure, peripheral oedema, and bone loss. However, the safety of partial perioxisome proliferator‐activated receptor‐γ agonists has not been esta